Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07519356) titled 'A Comprehensive Register Of Lymphoproliferative Disorders (ReLy)' on April 2.
Study Type: Observational [Patient Registry]
Primary Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia
Condition:
Lymphoproliferative Disease
Recruitment Status: Recruiting
Date of First Enrollment: June 9, 2022
Target Sample Size: 9000
Countries of Recruitment:
Italy
To know more, visit https://clinicaltrials.gov/study/NCT07519356
Published by HT Digital Content Services with permission from Health Daily Digest....